AGC Bio to sell two sites in Colorado, will lay off 278 workers in the processnews2025-09-17T14:41:51+00:00September 17th, 2025|Endpoints News|
GSK budgets $30B to boost US presencenews2025-09-16T23:01:44+00:00September 16th, 2025|Endpoints News|
Eli Lilly picks Virginia for $5B API site as part of $27B US pledgenews2025-09-16T14:30:17+00:00September 16th, 2025|Endpoints News|
Pharma mulls UK divestments as government action lags in life sciencesnews2025-09-15T17:48:49+00:00September 15th, 2025|Endpoints News|
LGC opens $72M chemical plant; Recipharm partners with NeuroSense news2025-09-11T15:12:39+00:00September 11th, 2025|Endpoints News|
Biocon eyes generic semaglutide market for 2026news2025-09-10T19:00:54+00:00September 10th, 2025|Endpoints News|
API maker Hikal hit with FDA warning letter over alleged metal contaminationnews2025-09-10T15:22:44+00:00September 10th, 2025|Endpoints News|
FDA blocks US imports from Sun Pharma’s Halol site over repeated issuesnews2025-09-10T13:59:27+00:00September 10th, 2025|Endpoints News|
Samsung Bio secures $1.3B contract with ‘large-sized’ US pharma customer news2025-09-09T16:38:49+00:00September 9th, 2025|Endpoints News|
Trump may exempt some pharma products from tariffs in future trade dealsnews2025-09-09T15:30:14+00:00September 9th, 2025|Endpoints News|
